COVID-19 Guidance for Behavioral Health Providers

Guidance for personnel in clinical and direct care settings to return to work following COVID-19 exposure or infection or travel. (Updated 12/28/21)

Preliminary guidance for reopening Opioid Treatment Program (OTP) services on a regional basis amid New York Forward and the evolving COVID-19 pandemic. (Updated 12/15/21)

OASAS re-opening guidance for funded and certified prevention programs offering prevention services. (updated 12/15/21)

Guidance on the new Part 808 COVID-19 mask wearing requirements in certified, funded or otherwise authorized settings.

COVID-19 Mask Wearing Requirements in Certified, Funded or Otherwise Authorized Settings. Open for public comment until 02/13/22.

This guidance provides information on SARS-CoV-2 (COVID-19) POC Ag testing for New York State (NYS) Office of Addiction Services and Supports (OASAS) licensed, funded, and...

An addendum to the 10/1/21 Guidance to OASAS Certified Programs about Addiction Treatment and Recovery Services during COVID-19 for residential and inpatient addiction treatment programs.

The CMS has revised requirements that Medicare/Medicaid-certified providers must meet including COVID-19 vaccination requirements for staff at certain OASAS facilities.

OASAS XR-Buprenorphine Guidance. 11/1/21

Interim infection control guidance for non-hospital based inpatient and residential addiction treatment providers amidst the COVID-19 pandemic. Issued 4/9/20. Updated 10/01/21.